Analyst Recommendations

Barclays analyst issues OVERWEIGHT recommendation on CVS at 2023-09-19 11:00:00. The previous analyst recommendation was .At the time of the issue of the analyst recommendation, the CVS was...

September 20, 2023   CVS 1.57%

JMP Securities analyst issues MARKET PERFORM recommendation on CVS at 2023-09-19 11:00:00. The previous analyst recommendation was .At the time of the issue of the analyst recommendation, the

September 20, 2023   CVS 1.57%

Citigroup analyst issues BUY recommendation on CVS at 2023-09-19 11:00:00. The previous analyst recommendation was .At the time of the issue of the analyst recommendation, the CVS was...

September 20, 2023   CVS 1.57%

Citigroup analyst issues NEUTRAL recommendation on CVS at 2023-09-19 11:00:00. The previous analyst recommendation was .At the time of the issue of the analyst recommendation, the CVS was...

September 20, 2023   CVS 1.57%

Cowen & Co. analyst issues MARKET PERFORM recommendation on CVS at 2023-09-19 11:00:00. The previous analyst recommendation was .At the time of the issue of the analyst recommendation, the...

September 20, 2023   CVS 1.57%

Morgan Stanley analyst issues EQUAL-WEIGHT recommendation on CVS at 2023-09-19 11:00:00. The previous analyst recommendation was Overweight.At the time of the issue of the analyst recommendation, the CVS...

September 20, 2023   CVS 1.57%

Jefferies analyst issues HOLD recommendation on CVS at 2023-09-19 11:00:00. The previous analyst recommendation was .At the time of the issue of the analyst recommendation, the CVS was...

September 20, 2023   CVS 1.57%

Jefferies analyst issues BUY recommendation on CVS at 2023-09-19 11:00:00. The previous analyst recommendation was .At the time of the issue of the analyst recommendation, the CVS was...

September 20, 2023   CVS 1.57%

Goldman Sachs analyst issues SELL recommendation on CCL at 2023-09-19 11:00:00. The previous analyst recommendation was .At the time of the issue of the analyst recommendation, the CCL...

September 20, 2023   CCL -1.63%

Raymond James analyst issues OUTPERFORM recommendation on CCL at 2023-09-19 11:00:00. The previous analyst recommendation was Strong Buy.At the time of the issue of the analyst recommendation, the

September 20, 2023   CCL -1.63%